- Home
- MHH vs ASRT Comparison
MHH vs ASRT Comparison
Compare MHH & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MHH | ASRT |
|---|---|---|
| Founded | 1986 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.7M | 76.0M |
| IPO Year | 2008 | 2004 |
Fundamental Metrics
Financial Performance| Metric | MHH | ASRT |
|---|---|---|
| Price | $6.16 | $18.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | 9.6K | ★ 146.7K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $191,371,000.00 | $118,713,000.00 |
| Revenue This Year | $2.93 | N/A |
| Revenue Next Year | $8.93 | $16.61 |
| P/E Ratio | $124.60 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.51 | $0.55 |
| 52 Week High | $8.47 | $20.45 |
Technical Indicators
Market Signals| Indicator | MHH | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 57.98 | 68.95 |
| Support Level | $5.53 | $0.70 |
| Resistance Level | $6.76 | $20.45 |
| Average True Range (ATR) | 0.41 | 1.36 |
| MACD | 0.06 | 0.14 |
| Stochastic Oscillator | 74.36 | 77.75 |
Price Performance
Historical ComparisonAbout MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.